{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T10:29:43Z","timestamp":1769768983653,"version":"3.49.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,1,16]]},"DOI":"10.7759\/cureus.33811","type":"journal-article","created":{"date-parts":[[2023,1,16]],"date-time":"2023-01-16T08:53:38Z","timestamp":1673859218000},"source":"Crossref","is-referenced-by-count":3,"title":["A Review of the Mechanism of Action of Drugs Used in Congestive Heart Failure in Pediatrics"],"prefix":"10.7759","author":[{"given":"Rakshit  K","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Revat J","family":"Meshram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aakriti","family":"Tiwari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.308996","article-title":"Heart failure in pediatric patients with congenital heart disease","volume":"120","author":"Hinton RB","year":"2017","unstructured":"Hinton RB, Ware SM. Heart failure in pediatric patients with congenital heart disease. Circ Res. 2017, 120:978-94. 10.1161\/CIRCRESAHA.116.308996","journal-title":"Circ Res"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007037.pub4","article-title":"Beta-blockers for congestive heart failure in children","volume":"7","author":"Alabed S","year":"2020","unstructured":"Alabed S, Sabouni A, Al Dakhoul S, Bdaiwi Y. Beta-blockers for congestive heart failure in children. Cochrane Database Syst Rev. 2020, 7:CD007037. 10.1002\/14651858.CD007037.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.21037\/cdt-20-358","article-title":"Medical management of pediatric heart failure","volume":"11","author":"Ahmed H","year":"2021","unstructured":"Ahmed H, VanderPluym C. Medical management of pediatric heart failure. Cardiovasc Diagn Ther. 2021, 11:323-35. 10.21037\/cdt-20-358","journal-title":"Cardiovasc Diagn Ther"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90789-1","article-title":"Epidemiology of congestive heart failure","volume":"55","author":"Smith WM","year":"1985","unstructured":"Smith WM. Epidemiology of congestive heart failure. Am J Cardiol. 1985, 55:3-8. 10.1016\/0002-9149(85)90789-1","journal-title":"Am J Cardiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2017.01.001","article-title":"Pediatric heart failure: a practical guide to diagnosis and management","volume":"58","author":"Masarone D","year":"2017","unstructured":"Masarone D, Valente F, Rubino M, et al.. Pediatric heart failure: a practical guide to diagnosis and management. Pediatr Neonatol. 2017, 58:303-12. 10.1016\/j.pedneo.2017.01.001","journal-title":"Pediatr Neonatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo M","year":"2020","unstructured":"Arrigo M, Jessup M, Mullens W, Reza N, Shah AM, Sliwa K, Mebazaa A. Acute heart failure. Nat Rev Dis Primers. 2020, 6:16. 10.1038\/s41572-020-0151-7","journal-title":"Nat Rev Dis Primers"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2020.06.020","article-title":"Sacubitril\/Valsartan: neprilysin iInhibition 5 years aAfter PARADIGM-HF","volume":"8","author":"Docherty KF","year":"2020","unstructured":"Docherty KF, Vaduganathan M, Solomon SD, McMurray JJ. Sacubitril\/Valsartan: neprilysin iInhibition 5 years aAfter PARADIGM-HF. JACC Heart Fail. 2020, 8:800-10. 10.1016\/j.jchf.2020.06.020","journal-title":"JACC Heart Fail"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-020-07071-0","article-title":"Inflammatory cytokines and chemokines as therapeutic targets in heart failure","volume":"34","author":"Hanna A","year":"2020","unstructured":"Hanna A, Frangogiannis NG. Inflammatory cytokines and chemokines as therapeutic targets in heart failure. Cardiovasc Drugs Ther. 2020, 34:849-63. 10.1007\/s10557-020-07071-0","journal-title":"Cardiovasc Drugs Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2021.06.011","article-title":"Drug layering in heart failure: phenotype-guided initiation","volume":"9","author":"Rosano GM","year":"2021","unstructured":"Rosano GM, Allen LA, Abdin A, et al.. Drug layering in heart failure: phenotype-guided initiation. JACC Heart Fail. 2021, 9:775-83. 10.1016\/j.jchf.2021.06.011","journal-title":"JACC Heart Fail"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/children8050322","article-title":"Current and future drug and device therapies for pediatric heart failure patients: potential lessons from adult trials","volume":"8","author":"Das BB","year":"2021","unstructured":"Das BB, Moskowitz WB, Butler J. Current and future drug and device therapies for pediatric heart failure patients: potential lessons from adult trials. Children (Basel). 2021, 8:322. 10.3390\/children8050322","journal-title":"Children (Basel)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3390\/children5070088","article-title":"Current state of pediatric heart failure","volume":"5","author":"Das BB","year":"2018","unstructured":"Das BB. Current state of pediatric heart failure. Children (Basel). 2018, 5:88. 10.3390\/children5070088","journal-title":"Children (Basel)"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/tp.2019.04.08","article-title":"Pediatric heart failure therapy: why \u03b21-receptor blocker, tissue ACE-I and mineralocorticoid-receptor-blocker?","volume":"8","author":"Recla S","year":"2019","unstructured":"Recla S, Schmidt D, Logeswaran T, Esmaeili A, Schranz D. Pediatric heart failure therapy: why \u03b21-receptor blocker, tissue ACE-I and mineralocorticoid-receptor-blocker?. Transl Pediatr. 2019, 8:127-32. 10.21037\/tp.2019.04.08","journal-title":"Transl Pediatr"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.97.14.1411","article-title":"Angiotensin-converting enzyme inhibitors","volume":"97","author":"Brown NJ","year":"1998","unstructured":"Brown NJ, Vaughan DE. Angiotensin-converting enzyme inhibitors. Circulation. 1998, 97:1411-20. 10.1161\/01.cir.97.14.1411","journal-title":"Circulation"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2007.01.069","article-title":"Are we misunderstanding beta-blockers","volume":"120","author":"Cruickshank JM","year":"2007","unstructured":"Cruickshank JM. Are we misunderstanding beta-blockers. Int J Cardiol. 2007, 120:10-27. 10.1016\/j.ijcard.2007.01.069","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.4103\/0253-7613.84947","article-title":"Inverse agonism and its therapeutic significance","volume":"43","author":"Khilnani G","year":"2011","unstructured":"Khilnani G, Khilnani AK. Inverse agonism and its therapeutic significance. Indian J Pharmacol. 2011, 43:492-501. 10.4103\/0253-7613.84947","journal-title":"Indian J Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.356014","article-title":"Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1)","volume":"287","author":"Somasekharan S","year":"2012","unstructured":"Somasekharan S, Tanis J, Forbush B. Loop diuretic and ion-binding residues revealed by scanning mutagenesis of transmembrane helix 3 (TM3) of Na-K-Cl cotransporter (NKCC1). J Biol Chem. 2012, 287:17308-17. 10.1074\/jbc.M112.356014","journal-title":"J Biol Chem"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/9713","article-title":"Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter","volume":"22","author":"Delpire E","year":"1999","unstructured":"Delpire E, Lu J, England R, Dull C, Thorne T. Deafness and imbalance associated with inactivation of the secretory Na-K-2Cl co-transporter. Nat Genet. 1999, 22:192-5. 10.1038\/9713","journal-title":"Nat Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00073.2007","article-title":"Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice","volume":"293","author":"Oppermann M","year":"2007","unstructured":"Oppermann M, Hansen PB, Castrop H, Schnermann J. Vasodilatation of afferent arterioles and paradoxical increase of renal vascular resistance by furosemide in mice. Am J Physiol Renal Physiol. 2007, 293:F279-87. 10.1152\/ajprenal.00073.2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00455.2004","article-title":"Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1\/BSC2) to renin secretion","volume":"289","author":"Castrop H","year":"2005","unstructured":"Castrop H, Lorenz JN, Hansen PB, et al.. Contribution of the basolateral isoform of the Na-K-2Cl- cotransporter (NKCC1\/BSC2) to renin secretion. Am J Physiol Renal Physiol. 2005, 289:F1185-92. 10.1152\/ajprenal.00455.2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1703100","article-title":"Diuretic treatment in heart failure","volume":"377","author":"Ellison DH","year":"2017","unstructured":"Ellison DH, Felker GM. Diuretic treatment in heart failure. N Engl J Med. 2017, 377:1964-75. 10.1056\/NEJMra1703100","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink HJ","year":"2016","unstructured":"Heerspink HJ, Perkins BA, Fitchett DH, Husain M, Cherney DZ. Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications. Circulation. 2016, 134:752-72. 10.1161\/CIRCULATIONAHA.116.021887","journal-title":"Circulation"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.7326\/M19-0085","article-title":"Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases","volume":"170","author":"Bersoff-Matcha SJ","year":"2019","unstructured":"Bersoff-Matcha SJ, Chamberlain C, Cao C, Kortepeter C, Chong WH. Fournier gangrene associated with sodium-glucose cotransporter-2 inhibitors: a review of spontaneous postmarketing cases. Ann Intern Med. 2019, 170:764-9. 10.7326\/M19-0085","journal-title":"Ann Intern Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-2316","article-title":"International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors","volume":"42","author":"Danne T","year":"2019","unstructured":"Danne T, Garg S, Peters AL, et al.. International consensus on risk management of diabetic ketoacidosis in patients with type 1 diabetes treated with sodium-glucose cotransporter (SGLT) inhibitors. Diabetes Care. 2019, 42:1147-54. 10.2337\/dc18-2316","journal-title":"Diabetes Care"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2299","article-title":"Heterotrimeric G protein activation by G-protein-coupled receptors","volume":"9","author":"Oldham WM","year":"2008","unstructured":"Oldham WM, Hamm HE. Heterotrimeric G protein activation by G-protein-coupled receptors. Nat Rev Mol Cell Biol. 2008, 9:60-71. 10.1038\/nrm2299","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/0092-8674(84)90336-2","article-title":"G proteins and dual control of adenylate cyclase","volume":"36","author":"Gilman AG","year":"1984","unstructured":"Gilman AG. G proteins and dual control of adenylate cyclase. Cell. 1984, 36:577-9. 10.1016\/0092-8674(84)90336-2","journal-title":"Cell"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nrm908","article-title":"Seven-transmembrane receptors","volume":"3","author":"Pierce KL","year":"2002","unstructured":"Pierce KL, Premont RT, Lefkowitz RJ. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002, 3:639-50. 10.1038\/nrm908","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/s0955-0674(97)80058-0","article-title":"Regulation of protein kinase C","volume":"9","author":"Newton AC","year":"1997","unstructured":"Newton AC. Regulation of protein kinase C. Curr Opin Cell Biol. 1997, 9:161-7. 10.1016\/s0955-0674(97)80058-0","journal-title":"Curr Opin Cell Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nature12000","article-title":"Conformational biosensors reveal GPCR signalling from endosomes","volume":"495","author":"Irannejad R","year":"2013","unstructured":"Irannejad R, Tomshine JC, Tomshine JR, et al.. Conformational biosensors reveal GPCR signalling from endosomes. Nature. 2013, 495:534-8. 10.1038\/nature12000","journal-title":"Nature"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2006.03.015","article-title":"Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes","volume":"71","author":"Boivin B","year":"2006","unstructured":"Boivin B, Lavoie C, Vaniotis G, et al.. Functional beta-adrenergic receptor signalling on nuclear membranes in adult rat and mouse ventricular cardiomyocytes. Cardiovasc Res. 2006, 71:69-78. 10.1016\/j.cardiores.2006.03.015","journal-title":"Cardiovasc Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M301738200","article-title":"Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes","volume":"278","author":"Boivin B","year":"2003","unstructured":"Boivin B, Chevalier D, Villeneuve LR, Rousseau E, Allen BG. Functional endothelin receptors are present on nuclei in cardiac ventricular myocytes. J Biol Chem. 2003, 278:29153-63. 10.1074\/jbc.M301738200","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.108.176024","article-title":"Nuclear alpha1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes","volume":"103","author":"Wright CD","year":"2008","unstructured":"Wright CD, Chen Q, Baye NL, Huang Y, Healy CL, Kasinathan S, O'Connell TD. Nuclear alpha1-adrenergic receptors signal activated ERK localization to caveolae in adult cardiac myocytes. Circ Res. 2008, 103:992-1000. 10.1161\/CIRCRESAHA.108.176024","journal-title":"Circ Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00700.2001","article-title":"Activation of cardiac ryanodine receptors by cardiac glycosides","volume":"282","author":"Sagawa T","year":"2002","unstructured":"Sagawa T, Sagawa K, Kelly JE, Tsushima RG, Wasserstrom JA. Activation of cardiac ryanodine receptors by cardiac glycosides. Am J Physiol Heart Circ Physiol. 2002, 282:H1118-26. 10.1152\/ajpheart.00700.2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure","volume":"336","year":"1997","unstructured":"The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997, 336.525-33. 10.1056\/NEJM199702203360801","journal-title":"N Engl J Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1542\/peds.50.1.6","article-title":"Umbilical artery catheterization: demonstration of arterial thrombosis by aortography","volume":"50","author":"Neal WA","year":"1972","unstructured":"Neal WA, Reynolds JW, Jarvis CW, Williams HJ. Umbilical artery catheterization: demonstration of arterial thrombosis by aortography. Pediatrics. 1972, 50:6-13. 10.1542\/peds.50.1.6","journal-title":"Pediatrics"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1754.1999.355392.x","article-title":"Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants","volume":"35","author":"Boo NY","year":"1999","unstructured":"Boo NY, Wong NC, Zulkifli SS, Lye MS. Risk factors associated with umbilical vascular catheter-associated thrombosis in newborn infants. J Paediatr Child Health. 1999, 35:460-5. 10.1046\/j.1440-1754.1999.355392.x","journal-title":"J Paediatr Child Health"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.74.5.1075","article-title":"Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure","volume":"74","author":"Armstrong PW","year":"1986","unstructured":"Armstrong PW, Stopps TP, Ford SE, de Bold AJ. Rapid ventricular pacing in the dog: pathophysiologic studies of heart failure. Circulation. 1986, 74:1075-84. 10.1161\/01.cir.74.5.1075","journal-title":"Circulation"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.2174\/1573403X12666151119165438","article-title":"Pharmacologic approach to heart failure in children","volume":"12","author":"Tume SC","year":"2016","unstructured":"Tume SC, Goldberg J, Molossi S, Bronicki RA. Pharmacologic approach to heart failure in children. Curr Cardiol Rev. 2016, 12:117-20. 10.2174\/1573403X12666151119165438","journal-title":"Curr Cardiol Rev"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/71.1.77","article-title":"Adrenoceptors as models for G protein-coupled receptors: structure, function and regulation","volume":"71","author":"Schwinn DA","year":"1993","unstructured":"Schwinn DA. Adrenoceptors as models for G protein-coupled receptors: structure, function and regulation. Br J Anaesth. 1993, 71:77-85. 10.1093\/bja\/71.1.77","journal-title":"Br J Anaesth"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1097\/00003246-199511000-00018","article-title":"Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery","volume":"23","author":"Chang AC","year":"1995","unstructured":"Chang AC, Atz AM, Wernovsky G, Burke RP, Wessel DL. Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med. 1995, 23:1907-14. 10.1097\/00003246-199511000-00018","journal-title":"Crit Care Med"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197409192911201","article-title":"Treatment of refractory heart failure with infusion of nitroprusside","volume":"291","author":"Guiha NH","year":"1974","unstructured":"Guiha NH, Cohn JN, Mikulic E, Franciosa JA, Limas CJ. Treatment of refractory heart failure with infusion of nitroprusside. N Engl J Med. 1974, 291:587-92. 10.1056\/NEJM197409192911201","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/48.7.651","article-title":"Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man","volume":"48","author":"Vesey CJ","year":"1976","unstructured":"Vesey CJ, Cole PV, Simpson PJ. Cyanide and thiocyanate concentrations following sodium nitroprusside infusion in man. Br J Anaesth. 1976, 48:651-60. 10.1093\/bja\/48.7.651","journal-title":"Br J Anaesth"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200603000-00024","article-title":"Levosimendan, a new inotropic and vasodilator agent","volume":"104","author":"Toller WG","year":"2006","unstructured":"Toller WG, Stranz C. Levosimendan, a new inotropic and vasodilator agent. Anesthesiology. 2006, 104:556-69. 10.1097\/00000542-200603000-00024","journal-title":"Anesthesiology"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001373","article-title":"HVAD usage and outcomes in the current pediatric ventricular assist device field: An advanced Cardiac Therapies Improving Outcomes Network (ACTION) analysis","volume":"67","author":"Auerbach SR","year":"2021","unstructured":"Auerbach SR, Simpson KE, Action Learning Network Investigators. HVAD usage and outcomes in the current pediatric ventricular assist device field: An advanced Cardiac Therapies Improving Outcomes Network (ACTION) analysis. ASAIO J. 2021, 67:675-80. 10.1097\/MAT.0000000000001373","journal-title":"ASAIO J"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2021.04.015","article-title":"ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association","volume":"40","author":"Lorts A","year":"2021","unstructured":"Lorts A, Conway J, Schweiger M, et al.. ISHLT consensus statement for the selection and management of pediatric and congenital heart disease patients on ventricular assist devices Endorsed by the American Heart Association. J Heart Lung Transplant. 2021, 40:709-32. 10.1016\/j.healun.2021.04.015","journal-title":"J Heart Lung Transplant"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/115019-a-review-of-the-mechanism-of-action-of-drugs-used-in-congestive-heart-failure-in-pediatrics","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:48:55Z","timestamp":1707508135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/115019-a-review-of-the-mechanism-of-action-of-drugs-used-in-congestive-heart-failure-in-pediatrics"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,16]]},"references-count":44,"URL":"https:\/\/doi.org\/10.7759\/cureus.33811","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1,16]]}}}